Heather A. Berger, Director at Design Therapeutics, Inc. (DSGN), bought 1,300 shares at $3.74 ($5K) on 2024-03-25, disclosed to the SEC on 2024-03-25.
Open-market purchase of $5k DSGN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.